Identification and validation of a poor clinical outcome subtype of primary prostate cancer with Midkine abundance

Recent studies identified Midkine (MDK) as playing a key role in immune regulation. In this study, we aimed to discover the clinical significance and translational relevance in prostate cancer (PCa). We retrospectively analyzed 759 PCa patients who underwent radical prostatectomy from Huashan Hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Quan, Yang, Chen, Mou, Zezhong, Wu, Siqi, Dai, Xiyu, Chen, Xinan, Ou, Yuxi, Zhang, Limin, Sha, Jianjun, Jiang, Haowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633304/
https://www.ncbi.nlm.nih.gov/pubmed/36018546
http://dx.doi.org/10.1111/cas.15546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633304/
https://www.ncbi.nlm.nih.gov/pubmed/36018546
http://dx.doi.org/10.1111/cas.15546

Ejemplares similares